FACULTY OF PHARMACY
M. Pharmacy (Pharmaceutics) I-Semester (Main & Backlog) Examination, February 2019
--- Content provided by FirstRanker.com ---
Subject : Regulatory Affairs
Time: 3 Hrs Max. Marks: 75
Note: Answer any Five Questions. All Questions Carry Equal Marks.
- (a) Describe various parts of master formula record and write its importance. 7
(b) Explain salient features of Hatch Waxman Act and its amendments. 8 - Enlist different sections of NDA and Write a note on NDA approval process. 15
- (a) Explain regulatory requirements of US registration for foreign drugs. 8
(b) Explain SUPAC guidelines specific to manufacturing changes 7 - (a) Describe the objectives of harmonization guidelines. Enlist ICH quality guidelines. 10
(b) Explain the objectives of CMC considerations during drug development. 5 - (a) Explain the regulatory requirement for biologics product approval. 8
(b) What is the purpose of Investigator’s Brochure? Give a brief note on the Information to be filled in each part of the IB. 7 - (a) Write a note on eCTD. 7
(b) Write different designs of BE studies for Generic drugs assessment. 8 - (a) Give an outline of factors that must be addressed in the clinical trial protocols as per USFDA check list. 8
--- Content provided by FirstRanker.com ---
(b) Give a brief note on Pharmacovigilance and safety monitoring in clinical trials. 7 - Write brief notes on:
- Regulatory requirements of EU 7
- Health Insurance Portability and Accountability Act. 8
--- Content provided by FirstRanker.com ---
--- Content provided by FirstRanker.com ---
--- Content provided by FirstRanker.com ---
This download link is referred from the post: OU M.Pharm Question Papers Last 10 Years 2010-2020 || Osmania University